JODI SANSON: Open Payments
NPI 1770538308 · HOT SPRINGS, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,415 in 74 payments from 19 companies in 2025. Trend: 2023 $1,532 · 2024 $1,330 · 2025 $1,415
Food & beverage: $1,415
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 13 | $313 |
| ABBVIE INC. | 22 | $308 |
| PFIZER INC. | 7 | $212 |
| AstraZeneca Pharmaceuticals LP | 8 | $151 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $54 |
| Exact Sciences Corporation | 3 | $45 |
| Abbott Laboratories | 2 | $42 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $42 |
| Antares Pharma, Inc. | 3 | $42 |
| Vanda Pharmaceuticals Inc. | 2 | $40 |
Products named: REXULTI, NURTEC ODT, VRAYLAR, UBRELVY, QULIPTA, AIRSUPRA, FARXIGA, CAPLYTA.
Industry payments across AR — which companies pay providers there.
